Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q83352950)
Watch
English
Hepatitis B virus infection
scientific article published on 01 February 2009
In more languages
default for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19217993
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19217993%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 January 2020
title
Hepatitis B virus infection
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19217993
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19217993%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 January 2020
main subject
Hepatitis B virus
1 reference
based on heuristic
inferred from title
virus
0 references
hepatitis B
1 reference
based on heuristic
inferred from title
author name string
Yun-Fan Liaw
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19217993
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19217993%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 January 2020
Chia-Ming Chu
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19217993
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19217993%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 January 2020
language of work or name
English
0 references
publication date
1 February 2009
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19217993
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19217993%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 January 2020
published in
The Lancet
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19217993
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19217993%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 January 2020
volume
373
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19217993
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19217993%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 January 2020
issue
9663
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19217993
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19217993%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 January 2020
page(s)
582-592
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19217993
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19217993%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 January 2020
cites work
Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Role of viral factors in the natural course and therapy of chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatitis B virus carrier state in black children in Ovamboland: role of perinatal and horizontal infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Secular trend of age-specific prevalence of hepatitis B surface and e antigenemia in pregnant women in Taiwan
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prevalence of HBV precore/core promoter variants in the United States
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
HBeAg-negative chronic hepatitis B: from obscurity to prominence
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Should hepatitis B vaccination be introduced into childhood immunisation programmes in northern Europe?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Two decades of universal hepatitis B vaccination in taiwan: impact and implication for future strategies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Nationwide hepatitis B vaccination program in Taiwan: effectiveness in the 20 years after it was launched.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dynamics of hepatitis B virus clearance in chimpanzees
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Role of hepatitis B virus specific cytotoxic T cells in liver damage and viral control
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immunopathogenesis: role of innate and adaptive immune responses
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chronic infections with hepatotropic viruses: mechanisms of impairment of cellular immune responses
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Increased incidence of fulminant hepatic failure in previously unrecognized HBsAg carriers with acute hepatitis independent of etiology
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Unrevealing the natural course of the so-called "inactive HBsAg or HBV carrier state".
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chronic hepatitis B: current testing strategies.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pediatric fulminant hepatic failure in endemic areas of hepatitis B infection: 15 years after universal hepatitis B vaccination
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mutations in the basic core promotor and the precore region of hepatitis B virus and their selection in children with fulminant and chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Occult hepatitis B virus infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Natural history of chronic hepatitis B virus infection in Taiwan: studies of hepatitis B virus DNA in serum
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term outcome of chronic hepatitis B in Caucasian patients: mortality after 25 years
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Viral hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Subcellular localization of hepatitis B core antigen in relation to hepatocyte regeneration in chronic hepatitis B
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Precore stop mutant in HBeAg-positive patients with chronic hepatitis B: clinical characteristics and correlation with the course of HBeAg-to-anti-HBe seroconversion
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Relationship between the development of precore and core promoter mutations and hepatitis B e antigen seroconversion in patients with chronic hepatitis B virus.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatitis flares and hepatitis B e antigen seroconversion: implication in anti-hepatitis B virus therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prognostic factors in severe exacerbation of chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Genotype C hepatitis B virus infection is associated with a higher risk of reactivation of hepatitis B and progression to cirrhosis than genotype B: a longitudinal study of hepatitis B e antigen-positive patients with normal aminotransferase levels
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chronic hepatitis B virus infection acquired in childhood: special emphasis on prognostic and therapeutic implication of delayed HBeAg seroconversion
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical relevance of hepatitis B virus genotype in children with chronic infection and hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Epidemiological study of hepatitis B virus genotypes, core promoter and precore mutations of chronic hepatitis B infection in Hong Kong.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clearance of hepatitis B e antigen in patients with chronic hepatitis B and genotypes A, B, C, D, and F
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Natural history of chronic HBV carriers in northern Italy: morbidity and mortality after 30 years.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Natural history of chronic HBV infection: a cohort study with up to 12 years follow-up in North Greece (part of the Interreg I-II/EC-project).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chronic hepatitis B in children after e antigen seroclearance: final report of a 29-year longitudinal study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Viremia profiles in children with chronic hepatitis B virus infection and spontaneous e antigen seroconversion
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
HBsAg seroclearance in asymptomatic carriers of high endemic areas: appreciably high rates during a long-term follow-up
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Influence of hepatitis B virus genotype on the long-term outcome of chronic hepatitis B in western patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
HBsAg seroclearance in chronic hepatitis B in the Chinese: virological, histological, and clinical aspects.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chronic hepatitis B e antigen (HBeAg) negative, anti-HBe positive hepatitis B: an overview
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Spontaneous relapse of hepatitis in inactive HBsAg carriers
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Predictive factors for reactivation of hepatitis B following hepatitis B e antigen seroconversion in chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatitis B virus DNA prediction rules for hepatitis B e antigen-negative chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Predicting cirrhosis risk based on the level of circulating hepatitis B viral load
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Risk and predictors of mortality associated with chronic hepatitis B infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The development of cirrhosis in patients with chronic type B hepatitis: A prospective study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatitis B e antigen and the risk of hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Significance of hepatitis B genotype in acute exacerbation, HBeAg seroconversion, cirrhosis-related complications, and hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of genotypes C and D of the hepatitis B virus in Japan: a clinical and molecular biological study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term outcome of chronic hepatitis B based on histological grade and stage.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Impact of acute hepatitis C virus superinfection in patients with chronic hepatitis B virus infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatitis B virus-related cirrhosis: natural history and treatment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Natural course following the onset of cirrhosis in patients with chronic hepatitis B: a long-term follow-up study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Familial risk of hepatocellular carcinoma among chronic hepatitis B carriers and their relatives
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Health-related quality of life in chronic hepatitis B patients.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The clinical significance of persistently normal ALT in chronic hepatitis B infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Interferon-alpha for HBeAg-positive chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Peginterferon alpha-2a (40 kDa): an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Outcome of hepatitis B e antigen-negative chronic hepatitis B on long-term nucleos(t)ide analog therapy starting with lamivudine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Predicting response to peginterferon alpha-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sustained response to peginterferon alfa-2a (40 kD) with or without lamivudine in Asian patients with HBeAg-positive and HBeAg-negative chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa-2a for HBeAg-positive chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Entecavir therapy for up to 96 weeks in patients with HBeAg-positive chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Telbivudine versus lamivudine in patients with chronic hepatitis B
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pretherapy alanine transaminase level as a determinant for hepatitis B e antigen seroconversion during lamivudine therapy in patients with chronic hepatitis B. Asian Hepatitis Lamivudine Trial Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Predictors of HBeAg loss after lamivudine treatment for chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The effect of lamivudine therapy in hepatic decompensation during acute exacerbation of chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Determinants of early mortality in patients with decompensated chronic hepatitis B treated with antiviral therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A United States compassionate use study of lamivudine treatment in nontransplantation candidates with decompensated hepatitis B virus-related cirrhosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B. Lamivudine Precore Mutant Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lamivudine for patients with chronic hepatitis B and advanced liver disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Histological outcome during long-term lamivudine therapy.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical outcome of HBeAg-negative chronic hepatitis B in relation to virological response to lamivudine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adding-on versus switching-to adefovir therapy in lamivudine-resistant HBeAg-negative chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Low resistance to adefovir combined with lamivudine: a 3-year study of 145 lamivudine-resistant hepatitis B patients.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatitis B: reflections on the current approach to antiviral therapy.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Successful Treatment with Peginterferon alfa-2b of HBeAg-positive HBV Non-Responders to Standard Interferon or Lamivudine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chronic hepatitis B: a global health problem requiring coherent worldwide treatment strategies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A 1-year trial of telbivudine, lamivudine, and the combination in patients with hepatitis B e antigen-positive chronic hepatitis B
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lamivudine compared with lamivudine and adefovir dipivoxil for the treatment of HBeAg-positive chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Management of hepatitis B: summary of a clinical research workshop
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatitis B reactivation after chemotherapy: two decades of clinical research
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960207-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0140-6736(09)60207-5
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19217993
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19217993%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 January 2020
PubMed publication ID
19217993
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19217993
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19217993%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 January 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
